# Clinical and Economic Burden of Bleeding Events in Patients in the UK With Non-valvular Atrial Fibrillation Treated With Vitamin k Antagonists

> **NCT02661516** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 16513 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02661516
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 16513 (ACTUAL)
- **Last updated:** 2016-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02661516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02661516, "Clinical and Economic Burden of Bleeding Events in Patients in the UK With Non-valvular Atrial Fibrillation Treated With Vitamin k Antagonists". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02661516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*